Create account

Coverage dated November 12, 2026 to November 13, 2026

The risk of blindness from GLP-1 drugs is too serious to ignore

Headline from The Hill

When a medication is prescribed to millions of people, even an uncommon complication can affect a substantial number of individuals.

The Hill's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

2 articles, oldest first.

  1. The Hill

    The risk of blindness from GLP-1 drugs is too serious to ignore (opens The Hill)

    Published

    The Hill's feed description

    When a medication is prescribed to millions of people, even an uncommon complication can affect a substantial number of individuals.

  2. Fortune

    GLP-1 drugs taken by 30 million Americans now carry an FDA warning for a rare ‘stroke of the eye’ that can cause vision loss (opens Fortune)

    Published

    Fortune's feed description

    The data on which the FDA’s warning is based suggests a real but low risk of NAION for people taking GLP-1 medications.

The risk of blindness from GLP-1 drugs is too serious to ignore | Since Then